United States · FDA National Drug Code directory
TECVAYLI
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 57894-450_5900ea09-1687-4d73-912f-5b0527cba6be
- Product NDC
- 57894-450
- Form
- INJECTION
- Composition / generic term
- teclistamab-cqyv
- Labeler
- Janssen Biotech, Inc.
- Marketing category
- BLA
- Marketing start / end (source format)
- 20221025
- Source listing expiry
- 20271231
Source-listed ingredients
- TECLISTAMAB — 90 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL, SINGLE-DOSE in 1 CARTON (57894-450-01) / 1.7 mL in 1 VIAL, SINGLE-DOSE · 57894-450-01
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →